Abstract
Purpose
Although colchicine has been tested in clinical trials for treatment of constipation, the index groups in those trials were composed of special patient groups with developmental neuromuscular defects or failed surgical management. The aim of this study is to investigate the efficacy of colchicine in patients with refractory slow transit constipation.
Materials and methods
Sixty patients with chief complaint of chronic constipation due to slow transit consented to be included in the double-blind placebo-controlled clinical trial. These patients were randomly divided into two groups (each containing 30 patients) to receive either colchicine, 1 mg QD, (group A) or placebo (group B) for 2 months. At the end of the study, Knowles–Eccersly–Scot symptom (KESS, a valid technique to assist in the diagnosis and evaluation of symptoms in constipation) scores were compared between the case and control groups.
Results
The mean KESS score measured at the end of 2 months was 11.67 ± 3.91 for colchicine and 18.66 ± 3.72 for placebo group (p = 0.0001).
Conclusion
This trial shows that low-dose colchicine is effective in treatment of slow transit constipation.
Similar content being viewed by others
References
Fauci AS, Brownwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J (eds) (2008) Harrison’s principle of internal medicine, 17th edn. Mc Graw-Hill, New York, pp. 1789–1791.
McCallum IJ, Ong S, Mercer-Jones M (2009) Chronic constipation in adults. BMJ 338:b831
Grotz RL, Pemberton JH, Levin KE et al (1993) Rectal wall contractility in healthy subjects and in patients with chronic severe constipation. Ann Surg 218:761–8
Lembo A, Camilleri M (2003) Chronic constipation. N Engl J Med 349:1360–1368
Bharucha AE (2007) Constipation. Best Pract Res Clin Gastroenterol 21:709–31
Ashraf W, Park F, Lof J, Quigley EM (1996) An examination of the reliability of reported stool frequency in the diagnosis of idiopathic constipation. Am J Gastroenterol 91:26–32
Rao SS, Tuteja AK, Vellema T, Kempf J, Stessman M (2004) Dyssynergic defecation: demographics, symptoms, stool patterns, and quality of life. J Clin Gastroenterol 38:680–5
Rao SS (2001) Dyssynergic defecation. Gastroenterol Clin North Am 30:97–114
Bassotti G, de Roberto G, Castellani D, Sediari L, Morelli A (2005) Normal aspects of colorectal motility and abnormalities in slow transit constipation. World J Gastroenterol 14:2691–6
Rao SS, Kuo B, McCallum RW, Chey WD, DiBaise JK, Hasler WL, Koch KL, Lackner JM, Miller C, Saad R, Semler JR, Sitrin MD, Wilding GE, Parkman HP (2009) Investigation of colonic and whole-gut transit with wireless motility capsule and radiopaque markers in constipation. Clin Gastroenterol Hepatol 7:537–44
Wong SW, Lubowski DZ (2007) Slow-transit constipation: evaluation and treatment. ANZ J Surg 77:320–8
Cortesini C, Cianchi F, Infantino A, Lise M (1995) Nitric oxide synthase and VIP distribution in enteric nervous system in idiopathic chronic constipation. Dig Dis Sci 40:2450–5
Lyford GL, He CL, Soffer E et al (2002) Pan-colonic decrease in interstitial cells of Cajal in patients with slow transit constipation. Gut 51:496–501
Tong WD, Liu BH, Zhang LY, Zhang SB, Lei Y (2004) Decreased interstitial cells of Cajal in the sigmoid colon of patients with slow transit constipation. Int J Colorectal Dis 19:467–73
Wedel T, Spiegler J, Soellner S, Roblick UJ, Schiedeck TH, Bruch HP, Krammer HJ (2002) Enteric nerves and interstitial cells of Cajal are altered in patients with slow-transit constipation and megacolon. Gastroenterology 123:1459–67
Johanson JF, Wald A, Tougas G et al (2004) Effect of tegaserod in chronic constipation: a randomized, double-blind, controlled trial. Clin Gastroenterol Hepatol 2:796–805
Ohlsson B, Truedsson M, Bengtsson M et al (2005) Effects of long-term treatment with oxytocin in chronic constipation; a double blind, placebo-controlled pilot trial. Neurogastroenterol Motil 17:697–704
Tack J, Middleton SJ, Horne MC et al (2006) Pilot study of the efficacy of renzapride on gastrointestinal motility and symptoms in patients with constipation-predominant irritable bowel syndrome. Aliment Pharmacol Ther 23:1655–65
Bak YT, Kim JH, Lee CH (1996) Cisapride in chronic idiopathic constipation: clinical response and effect on colonic transit time. Korean J Intern Med 11:151–6
Soffer EE, Metcalf A, Launspach J (1994) Misoprostol is effective treatment for patients with severe chronic constipation. Dig Dis Sci 39:929–33
Castillejo G, Bulló M, Anguera A et al (2006) A controlled, randomized, double-blind trial to evaluate the effect of a supplement of cocoa husk that is rich in dietary fiber on colonic transit in constipated pediatric patients. Pediatrics 118:641–8
Pemberton JH, Rath DM, Ilstrup DM (1991) Evaluation and surgical treatment of severe chronic constipation. Ann Surg 214:403–11
Wexner SD, Daniel N, Jagelman DG et al (1991) Colectomy for constipation: physiologic investigation is the key to success. Dis Colon Rectum 34:851–6
Eaker EY, Sninsky CA (1987) Taxol, a microtubular stabilizer, blocks the effects of colchicine on intestinal motility. Gastroenterology 92:A1379
Levy M, Spino M, Read SE (1991) Colchicine: a state-of-the art review. Pharmacotherapy 11:196–211
Sninsky CA, Lynch DF (1986) Why should microtubular inhibitors induce frequent activity fronts (AF) of the migrating myoelectric complex (MMC)? Gastroenterology 90:1641
Venho VM, Koivuniemi A (1978) Effect of colchicine on drug absorption from the rat small intestine in situ and in vitro. Acta Pharmacol Toxicol 43:251–259
Rachmilewitz D, Karmeli F (1980) Effect of colchicine on jejunal adenylate cyclase activity, PGE2, and cAMP contents. Eur J Pharmacol 67:235–239
Frame PS, Dolan P, Kohli R et al (1998) Use of colchicine to treat severe constipation in developmentally disabled patients. J Am Board Fam Pract 11:341–6
Rajapakse R, Warman J, Korelits BI (2001) Colchicin for persistant constipation after total abdominal colectomy with iliorectostomy for colonic inertia. J Clin Gastroentrol 33:81–4
Wald A (2002) Slow transit constipation. Curr Treat Options Gastroenterol 5:279–283
Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC (2006) Functional bowel disorders. Gastroenterology 130:1480–91
Knowles CH, Eccersley AJ, Scott SM, Walker SM, Reeves B, Lunniss PJ (2000) Linear discriminant analysis of symptoms in patients with chronic constipation: validation of a new scoring system (KESS). Dis Colon Rectum 43:1419–26
Rao SS (2003) Constipation: evaluation and treatment. Gastroenterol Clin North Am 32:659–683
Pohl D, Tutuian R, Fried M (2008) Pharmacologic treatment of constipation: what is new? Curr Opin Pharmacol 8:724–8
Ramkumar D, Rao S (2005) Efficacy and safety of traditional medical therapies for chronic constipation: systematic review. Am J Gastroenterol 4:936–71
Locke GR, Pemberton JH, Phillips SF (2000) AGA technical review on constipation. Gastroenterology 119:1766–78
Potet F, Bouyssou T, Escande D, Baró I (2001) Gastrointestinal prokinetic drugs have different affinity for the human cardiac human ether-à-gogo K(+) channel. J Pharmacol Exp Ther 299:1007–12
Mohammad S, Zhou Z, Gong Q, January CT (1997) Blockage of the HERG human cardiac K+ channel by the gastrointestinal prokinetic agent cisapride. Am J Physiol 273:2534–8
Brinker AD, Mackey AC, Prizont R (2004) Tegaserod and ischemic colitis. N Engl J Med 351:1361–4
Johanson JF, Drossman DA, Panas R, Wahle A, Ueno R (2008) Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation. Aliment Pharmacol Ther 27:685–96
Roarty TP, Weber F, Soykan I, McCallum RW (1997) Misoprostol in the treatment of chronic refractory constipation: results of a long-term open label trial. Aliment Pharmacol Ther 11:1059–66
Knowles CH, Scott M, Lunniss PJ (1999) Outcome of colectomy for slow transit constipation. Ann Surg 230:627–638
Hart J, Lewin KJ, Peters RS et al (1993) Effect of long-term colchicine therapy on jejunal mucosa. Dig Dis Sci 38:2017–21
Verne GN, Davis RH, Robinson ME et al (2003) Treatment of chronic constipation with colchicine: randomized, double-blind, placebo-controlled, crossover trial. Am J Gastroenterol 98:1112–6
Ehrenfeld M, Levy M, Sharon P (1982) Gastrointestinal side effects of long-term colchicine therapy in patients with recurrent polyserositis (familial Mediterranean fever). Dig Dis Sci 27:723–727
Race TF, Paes IC, Faloon WW (1970) Intestinal malabsorption induced by oral colchicine. Comparison with neomycin and cathartic agents. Am J Med Sci 259:32–41
Kuncl RW, Duncan G, Watson D et al (1987) Colchicine myopathy and neuropathy. N Engl J Med 316:1562–68
Acknowledgment
This study was funded in full by the research council of Shiraz University of Medical Sciences. The writing and initial data analyses were supported by Shiraz University of Medical Sciences.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Taghavi, S.A., Shabani, S., Mehramiri, A. et al. Colchicine is effective for short-term treatment of slow transit constipation: a double-blind placebo-controlled clinical trial. Int J Colorectal Dis 25, 389–394 (2010). https://doi.org/10.1007/s00384-009-0794-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-009-0794-z